Jovanka King

547 total citations
16 papers, 275 citations indexed

About

Jovanka King is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Jovanka King has authored 16 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Epidemiology. Recurrent topics in Jovanka King's work include Immunodeficiency and Autoimmune Disorders (9 papers), Cystic Fibrosis Research Advances (3 papers) and Respiratory viral infections research (2 papers). Jovanka King is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (9 papers), Cystic Fibrosis Research Advances (3 papers) and Respiratory viral infections research (2 papers). Jovanka King collaborates with scholars based in Australia, Sweden and United States. Jovanka King's co-authors include Lennart Hammarström, Jacek Winiarski, Susanne Jönsson, Michela Barbaro, Annika Ohlsson, Stephan Borte, Rolf Zetterström, Ulrika von Döbeln, Luigi D. Notarangelo and Kalle Grill and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Allergy and Clinical Immunology and Thorax.

In The Last Decade

Jovanka King

13 papers receiving 273 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jovanka King Australia 7 196 128 82 60 38 16 275
Maartje Blom Netherlands 11 165 0.8× 105 0.8× 82 1.0× 51 0.8× 33 0.9× 16 245
Nermeen Galal Egypt 11 243 1.2× 94 0.7× 54 0.7× 70 1.2× 16 0.4× 34 310
Revathi Raj India 10 114 0.6× 51 0.4× 31 0.4× 51 0.8× 51 1.3× 74 329
Marina García-Prat Spain 9 185 0.9× 76 0.6× 43 0.5× 72 1.2× 29 0.8× 20 281
Ibtihal Benhsaien Morocco 7 230 1.2× 96 0.8× 71 0.9× 81 1.4× 28 0.7× 25 273
Giorgia Bucciol Belgium 9 148 0.8× 63 0.5× 36 0.4× 53 0.9× 14 0.4× 15 226
Salem Al‐Tamemi Oman 10 112 0.6× 41 0.3× 43 0.5× 40 0.7× 17 0.4× 33 222
Andrea Martín-Nalda Spain 7 101 0.5× 51 0.4× 38 0.5× 36 0.6× 15 0.4× 10 139
Zoe Allwood United Kingdom 4 210 1.1× 76 0.6× 68 0.8× 58 1.0× 27 0.7× 5 226
Masaharu Tamaki Japan 9 53 0.3× 20 0.2× 19 0.2× 67 1.1× 20 0.5× 48 201

Countries citing papers authored by Jovanka King

Since Specialization
Citations

This map shows the geographic impact of Jovanka King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jovanka King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jovanka King more than expected).

Fields of papers citing papers by Jovanka King

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jovanka King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jovanka King. The network helps show where Jovanka King may publish in the future.

Co-authorship network of co-authors of Jovanka King

This figure shows the co-authorship network connecting the top 25 collaborators of Jovanka King. A scholar is included among the top collaborators of Jovanka King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jovanka King. Jovanka King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Chia, Nicholas, et al.. (2025). Commercial immunoassays in paraneoplastic neurological syndromes: an Australian laboratory perspective. Frontiers in Neurology. 16. 1515069–1515069. 1 indexed citations
2.
Rozek, Tomas, et al.. (2024). The Multi-Omic Approach to Newborn Screening: Opportunities and Challenges. International Journal of Neonatal Screening. 10(3). 42–42. 6 indexed citations
3.
Aggarwal, Anupriya, Anouschka Akerman, Vanessa Milogiannakis, et al.. (2023). Immunoglobulin repertoire restriction characterizes the serological responses of patients with predominantly antibody deficiency. Journal of Allergy and Clinical Immunology. 152(1). 290–301.e7.
4.
King, Jovanka, Kalle Grill, & Lennart Hammarström. (2023). Genomic-Based Newborn Screening for Inborn Errors of Immunity: Practical and Ethical Considerations. International Journal of Neonatal Screening. 9(2). 22–22. 16 indexed citations
5.
Edwards, Suzanne, et al.. (2023). Can C-Reactive Protein be Used As a Surrogate Marker of IL-6 in a Broad Array Of Clinical Entities?. Biomarkers in Medicine. 17(24). 1001–1010. 3 indexed citations
6.
King, Jovanka, Luigi D. Notarangelo, & Lennart Hammarström. (2021). An appraisal of the Wilson & Jungner criteria in the context of genomic-based newborn screening for inborn errors of immunity. Journal of Allergy and Clinical Immunology. 147(2). 428–438. 23 indexed citations
7.
Yeoh, Daniel K., Christopher C. Blyth, Anita J Campbell, et al.. (2021). Acute haemoptysis, fever and abdominal pain in an adolescent from northern Australia. Thorax. 76(9). 951–953.
8.
King, Jovanka, et al.. (2020). Vedolizumab is safe and effective in the treatment of X-linked agammaglobulinemia–associated inflammatory bowel disease. The Journal of Allergy and Clinical Immunology In Practice. 9(2). 1006–1007. 1 indexed citations
9.
King, Jovanka, Jezabel Varadé, & Lennart Hammarström. (2018). Fucosyltransferase Gene Polymorphisms and Lewisb-Negative Status Are Frequent in Swedish Newborns, With Implications for Infectious Disease Susceptibility and Personalized Medicine. Journal of the Pediatric Infectious Diseases Society. 8(6). 507–518. 12 indexed citations
10.
King, Jovanka & Lennart Hammarström. (2017). Newborn Screening for Primary Immunodeficiency Diseases: History, Current and Future Practice. Journal of Clinical Immunology. 38(1). 56–66. 90 indexed citations
11.
Quinn, Patrick, Annie L.M. Cheung, Jovanka King, et al.. (2017). P84: COMBINED IMMUNODEFICIENCY DUE TO DEFICIENCY OF ACTINRELATED PROTEIN COMPLEX 1B (ARPC1B). Internal Medicine Journal. 47(S5). 29–30. 2 indexed citations
12.
Gold, Michael R., et al.. (2017). P80: INTUSSCEPTION: A NOVEL PRESENTATION OF ACTIVATED PHOSPHOINOSITIDE 3‐KINASE‐Δ (PI3KΔ) SYNDROME (APDS). Internal Medicine Journal. 47(S5). 28–29.
13.
King, Jovanka, Jonas F. Ludvigsson, & Lennart Hammarström. (2017). Newborn Screening for Primary Immunodeficiency Diseases: The Past, the Present and the Future. International Journal of Neonatal Screening. 3(3). 19–19. 13 indexed citations
14.
Barbaro, Michela, Annika Ohlsson, Stephan Borte, et al.. (2016). Newborn Screening for Severe Primary Immunodeficiency Diseases in Sweden—a 2-Year Pilot TREC and KREC Screening Study. Journal of Clinical Immunology. 37(1). 51–60. 100 indexed citations
15.
King, Jovanka & Pravin Hissaria. (2014). Parasitic Infection and Immunomodulation: A Possible Explanation for the Hygiene Hypothesis in Autoimmune and Allergic Disease. SHILAP Revista de lepidopterología. 11(3). 197–200. 1 indexed citations
16.
Anderson, Wayne I., et al.. (1989). Nasal cavernous haemangioma in an American short haired cat. Veterinary Record. 124(2). 41–41. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maartje Blom Breakdown of academic impact, for papers by Nermeen Galal Breakdown of academic impact, for papers by Revathi Raj Breakdown of academic impact, for papers by Marina García-Prat Breakdown of academic impact, for papers by Ibtihal Benhsaien Breakdown of academic impact, for papers by Giorgia Bucciol Breakdown of academic impact, for papers by Salem Al‐Tamemi Breakdown of academic impact, for papers by Andrea Martín-Nalda Breakdown of academic impact, for papers by Zoe Allwood Breakdown of academic impact, for papers by Masaharu Tamaki
Rankless by CCL
2026